Literature DB >> 11786732

Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa.

S Papadopoulou1, A Scorilas, N Arnogianaki, B Papapanayiotou, A Tzimogiani, N Agnantis, M Talieri.   

Abstract

Proteolytic enzymes, such as type IV collagenases (MMP-2 gelatinase A, 72-kD type IV collagenase and MMP-9 gelatinase B, 92-kD type IV collagenase) play an important role in tumor invasion and metastasis. In the present study the levels of MMP-2 antigenic concentration and immunohistochemical staining were compared in paired colorectal tumor (n = 64) and background colon tissue of the same patients with clinical and pathological staging. The antigenic concentrations were found to be statistically significantly higher in cancer tissue (mean 11.29 ng/mg protein) than in corresponding normal mucosa (10.23 ng/mg protein) (p = 0.008). There was also a positive correlation between MMP-2 antigenic concentration and clinicopathologic parameters such as grade (p < 0.001) and Dukes' stage (p = 0.001), but not with lymph node involvement. Immunohistological localization of MMP-2 was observed in tumor as well as in stromal cells. Staining intensity increased from adenoma to adenocarcinoma. The degree of staining was associated with grade (p < 0.001), Dukes' stage (p < 0.001) and lymph node involvement (p < 0.001). Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11786732     DOI: 10.1159/000050641

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  12 in total

Review 1.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumors.

Authors:  Takahiro Nemoto; Shunichiro Kubota; Hideyuki Ishida; Nobuo Murata; Daijo Hashimoto
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

3.  Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.

Authors:  László Herszényi; Ferenc Sipos; Orsolya Galamb; Norbert Solymosi; István Hritz; Pál Miheller; Lajos Berczi; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2008-03-18       Impact factor: 3.201

4.  Dynamic Switch Between Two Adhesion Phenotypes in Colorectal Cancer Cells.

Authors:  Yue Geng; Siddarth Chandrasekaran; Sivaprakash Agastin; Jiahe Li; Michael R King
Journal:  Cell Mol Bioeng       Date:  2013-11-14       Impact factor: 2.321

Review 5.  Prognostic value of innate and adaptive immunity in colorectal cancer.

Authors:  Fabio Grizzi; Paolo Bianchi; Alberto Malesci; Luigi Laghi
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

6.  Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer.

Authors:  Zeljko Sundov; Snjezana Tomić; Katarina Vilović; Nenad Kunac; Marija Kalebić; Josko Bezić
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

7.  Active MMP-2 effectively identifies the presence of colorectal cancer.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; Veronica Klepeis; John B Willett
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

8.  Matrix metalloproteinase-2 and -7 expression in colorectal cancer.

Authors:  Seong Woo Hong; Yun Kyung Kang; Byungmo Lee; Woo Yong Lee; Yeo Gu Jang; In Wook Paik; Hyucksang Lee
Journal:  J Korean Soc Coloproctol       Date:  2011-06-30

9.  The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.

Authors:  A Hettiaratchi; N J Hawkins; G McKenzie; R L Ward; J E Hunt; D Wakefield; N Di Girolamo
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

10.  Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer.

Authors:  Selja Koskensalo; Jaana Hagström; Nina Linder; Mikael Lundin; Timo Sorsa; Johanna Louhimo; Caj Haglund
Journal:  BMC Clin Pathol       Date:  2012-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.